Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!

HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
MISTR: DoxyPEP helps reduce STIs among patients by 50 percent
dallasvoice.com
In just 12 months, more than 74 percent of patients now request DoxyPEP bundled with their PrEP prescriptions, “highlighting massive demand for this underutilized prevention tool.”MISTR's Free DoxyPEP Leads to Huge Drop in STI Rates
www.metroweekly.com
The telehealth platform MISTR reports that its efforts to connect patients with DoxyPEP has led to a more than 50% drop in STI diagnoses.New Jersey could lose HIV funding
outinjersey.net
Recently, the Wall Street Journal reported that the Trump administration is considering eliminating all CDC domestic HIV funding or transferring its programs to another federal agency. Carl Schmid,...